Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

In re Yasmin and Yaz Marketing

July 19, 2010

IN RE YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND RELEVANT PRODUCTS LIABILITY LITIGATION
THIS DOCUMENT RELATES TO: JANA SMITH, PLAINTIFF
v.
BAYER HEALTHCARE PHARMACEUTICALS ET AL DEFENDANTS



The opinion of the court was delivered by: Judge David R. Herndon

MDL No. 2100

ORDER

This matter is before the Court on Plaintiff's motion for leave to file her first amended complaint pursuant to Federal Rule of Civil Procedure 15(c) (Doc. 9) for the purpose of adding Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc., the entities that purportedly produced and distributed Ocella (generic Yasmin). Defendants have not responded to Plaintiff's motion for leave to amend.

Upon consideration of Plaintiff's motion, the Court finds as follows:

Plaintiff's Motion to file First Amended Complaint (Doc. 9) is GRANTED. Further, the Court DIRECTS Plaintiff to file the amended complaint instanter.

SO ORDERED:

David R. Herndon Chief Judge United States District Court

20100719

© 1992-2010 VersusLaw ...

Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.